---
category: news
title: "Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform"
excerpt: "Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence (\"A.I.\") platform to transform the cost, pace, and timeline of oncology drug discovery and development,"
publishedDateTime: 2021-05-03T13:00:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-and-actuate-therapeutics-announce-research-development-collaboration-leveraging-lantern-s-artificial-intelligence-platform-1030377828"
webUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-and-actuate-therapeutics-announce-research-development-collaboration-leveraging-lantern-s-artificial-intelligence-platform-1030377828"
type: article
quality: 35
heat: 35
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
    width: 400
    height: 296
    isCached: true

related:
  - title: "Hepion Pharmaceuticals Presents Machine Learning “Learn and Confirm” Modeling Strategy at 4th Global NASH Congress"
    excerpt: "Hepion Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on Artificial Intelligence- driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis and liver disease,"
    publishedDateTime: 2021-04-29T13:50:00Z
    webUrl: "https://www.nasdaq.com/press-release/hepion-pharmaceuticals-presents-machine-learning-learn-and-confirm-modeling-strategy"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 27
  - title: "Hepion Pharmaceuticals Presents Machine Learning “Learn and Confirm” Modeling Strategy at 4th ..."
    excerpt: "Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”) - driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and liver disease,"
    publishedDateTime: 2021-04-29T13:52:00Z
    webUrl: "https://apnews.com/press-release/globe-newswire/business-health-coronavirus-technology-87219646d2d65bc37f996c264e72bef7"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 26
    images:
      - url: "https://apnews.com/images/PaidContent3.png"
        width: 700
        height: 450
        isCached: true

secured: "IUP4rpajfLZ9xDpGHyFE0XXvPMldO8Oz+WDq6e7C9aKEZ30fgDjsbPxgHK9G3IRx0pWtjPwZuZPSI5ofacvhuuzU0fvAPmE5NtP2dGQV9bmmWuEk6ForfZVGiSz704BymHKZbpEur+JFPns4VZVOTJI2jdK4j0TSyTSao3Y4JkuNnfvpd3lutYKujIFcCC6H6VOap7f4AYB1Z3iBjMHfABzugqyt9rm+iP7ESdx7UJxRp3zH2sI7u21teDMFqedTwlhdHDdSI39dLn++j2xN5GZOb4BCGTg1godKx5gI+iFF9aXm03jwdPbvDfSi78Ve1UFmbN2P61/72KWKBSfIPPxM0ZXXaFFKOzHsYtC/F7E=;glMLBmLjd2Mp8DBwqJ5vJQ=="
---

